ArticleAntimicrobial agents and chemotherapy2020
Genomic Epidemiology of Complex, Multispecies, Plasmid-Borne
Open access · greenAbstract read
In one paragraph
Article in Antimicrobial agents and chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.
0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 46 citations in OpenAlex.
- Clonal dissemination and plasmid plasticity of KPC-3-producing Klebsiella pneumoniae ST512 during a hospital outbreak in Spain.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026Article
- Plasmid dynamics driving carbapenemase gene dissemination in healthcare environments: a nationwide analysis of closed Enterobacterales genomes.Nature communications · 2025Article
- Beyond the Spotlight:Antibiotics (Basel, Switzerland) · 2025Review
- Characterization of Carbapenem-Resistant Gram-Negative Bacilli Isolates in Multispecialty Private Hospitals in Lagos, Nigeria.Infectious disease reports · 2025Article
- Global Epidemiology and Antimicrobial Resistance of Klebsiella Pneumoniae Carbapenemase (KPC)-Producing Gram-Negative Clinical Isolates: A Review.Microorganisms · 2025Review
- The dark matter of bacterial genomic surveillance-antimicrobial resistance plasmid transmissions in the hospital setting.Journal of clinical microbiology · 2025Article
- The global prevalence, formation, and evolutionary inference of bacteria co-carrying theFrontiers in microbiology · 2025Article
- Plasmid-Mediated Spread of Carbapenem Resistance inAntibiotics (Basel, Switzerland) · 2024Article
- A Multiplex Recombinase-Aided qPCR Assay for Highly Sensitive and Rapid Detection of khe, blaJournal of clinical laboratory analysis · 2024Article
- Genome sequencing unveilsmSystems · 2024Article
- Plasmid genomic epidemiology ofAntimicrobial agents and chemotherapy · 2023Article
- Genomic dissection of endemic carbapenem resistance reveals metallo-beta-lactamase dissemination through clonal, plasmid and integron transfer.Nature communications · 2023Article
- Long-read sequencing reveals genomic diversity and associated plasmid movement of carbapenemase-producing bacteria in a UK hospital over 6 years.Microbial genomics · 2023Article
- Multicentre genetic diversity study of carbapenem-resistant Enterobacterales: predominance of untypeable pUVA-likeJAC-antimicrobial resistance · 2023Article
- [Therapy-relevant antibiotic resistances in a One Health context].Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2023Review
- Genomic surveillance of multidrug-resistantMicrobial genomics · 2023Article
- Taking hospital pathogen surveillance to the next level.Microbial genomics · 2023Article
- In situ, in vivo, and in vitro approaches for studying AMR plasmid conjugation in the gut microbiome.FEMS microbiology reviews · 2023Review
- Genomic Epidemiology of Carbapenemase-producing Klebsiella pneumoniae in China.Genomics, proteomics & bioinformatics · 2022Article
- Carbapenemase-Encoding Gene Copy Number Estimator (CCNE): a Tool for Carbapenemase Gene Copy Number Estimation.Microbiology spectrum · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors at 5 institutions in 2 countries.
Nicole Stoesser *Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom nicole.stoesser@ndm.ox.ac.uk.ORCID 0000-0002-4508-7969
Hang T T Phan *NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, University of Oxford, Oxford, United Kingdom.
Anna C SealeNuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
Zoie AikenManchester University NHS Foundation Trust, Manchester, United Kingdom.
Stephanie ThomasManchester University NHS Foundation Trust, Manchester, United Kingdom.
Matthew SmithManchester University NHS Foundation Trust, Manchester, United Kingdom.
David WyllieNuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-9155-6228
Ryan GeorgeManchester University NHS Foundation Trust, Manchester, United Kingdom.
Robert SebraIcahn Institute and Department of Genetics and Genomic Sciences, Icahn School of Medicine, Mount Sinai, New York, USA.
Amy J MathersDivision of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia, USA.
Alison VaughanNuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
Timothy E A PetoNuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
Matthew J EllingtonAntimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit, National Infection Service, Public Health England, London, United Kingdom.
Katie L HopkinsAntimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit, National Infection Service, Public Health England, London, United Kingdom.
Derrick W CrookNuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
Alex OrlekNuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
William WelfarePublic Health England North West, Manchester, United Kingdom.
Julie CawthorneManchester University NHS Foundation Trust, Manchester, United Kingdom.
Cheryl LenneyManchester University NHS Foundation Trust, Manchester, United Kingdom.
Andrew DodgsonManchester University NHS Foundation Trust, Manchester, United Kingdom.
Neil WoodfordAntimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit, National Infection Service, Public Health England, London, United Kingdom.
A Sarah WalkerNuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
TRACE Investigators’ Group
University of Oxford · GBPublic Health England · GBManchester University NHS Foundation Trust · GBUniversity of Virginia Health System · USIcahn School of Medicine at Mount Sinai · US
Funding
No grant is acknowledged in the PubMed record.
Abstract
Carbapenem resistance in
Indexed as
Molecular EpidemiologyAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenemsDNA, BacterialDrug Resistance, BacterialEnterobacteriaceaeEnterobacteriaceae InfectionsGenome, BacterialHumansKlebsiella InfectionsPlasmidsRetrospective StudiesUnited KingdomWhole Genome SequencingAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseCarbapenemsDNA, BacterialcarbapenemaseEnterobacteralesgenomic epidemiologyKPClong-read sequencingoutbreak analysisshort-read sequencingwhole-genome sequencing
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.